House committee launches investigation into Eli Lilly's China clinical trials at military hospitals and Xinjiang facilities, citing biotech risks.
<iframe src="https://statesidedaily.com/embed/cluster/f3c74ddce4cbd73b3e57663944bc0adfec57eb73" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Lawmakers press Eli Lilly for China drug trials tied to military-linked hospitals"></iframe>
House committee launches investigation into Eli Lilly's China clinical trials at military hospitals and Xinjiang facilities, citing biotech risks.
